反応式
[CH2:1]([O:8][C:9]([N:11]([CH2:25][C:26]1[CH:31]=[CH:30][CH:29]=[C:28]([C:32]([F:35])([F:34])[F:33])[CH:27]=1)[C:12]1[C:17](=[O:18])[N:16]2[C@H:19]([C:22](O)=[O:23])[CH2:20][CH2:21][C:15]2=[N:14][CH:13]=1)=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:36]([O:40][C:41](=[O:53])[NH:42][C:43]([C:45]1[CH:50]=[CH:49][C:48]([CH2:51][NH2:52])=[CH:47][CH:46]=1)=[NH:44])([CH3:39])([CH3:38])[CH3:37].C([O-])(O)=O.[Na+].C1C=NC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C>CCOC(C)=O.C(Cl)Cl.CN(C=O)C>[C:36]([O:40][C:41]([NH:42][C:43](=[NH:44])[C:45]1[CH:46]=[CH:47][C:48]([CH2:51][NH:52][C:22]([C@H:19]2[N:16]3[C:17](=[O:18])[C:12]([N:11]([CH2:25][C:26]4[CH:31]=[CH:30][CH:29]=[C:28]([C:32]([F:34])([F:35])[F:33])[CH:27]=4)[C:9](=[O:10])[O:8][CH2:1][C:2]4[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=4)=[CH:13][N:14]=[C:15]3[CH2:21][CH2:20]2)=[O:23])=[CH:49][CH:50]=1)=[O:53])([CH3:39])([CH3:37])[CH3:38]参加物
8
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of intermediate 25a (0.281 mmol) and [(4-aminomethyl-phenyl)-imino-methyl]-carbamic acid tert-butyl ester (84 mg, 0.337 mmol) in 3 mL 5:1 CH2Cl2/DMF at 0° C., were added NaHCO3 (59 mg, 0.703 mmol), HOAT (42.1 mg, 0.309 mmol), and EDCI (75.5 mg, 0.393 mmol). The mixture was allowed to warm to rt and stir 20 h, then was diluted with EtOAc. The organic phase was washed with H2O, 1N HCl, H2O, and sat. NaHCO3, and brine, dried (Na2SO4) and brine. The crude residue was triturated with Et2O to afford 160 mg (79%) of intermediate 25b as a white solid. MS (ESI) 719.4 (M+H+).
後処理
- washThe organic phase was washed with H2O, 1N HCl, H2O, and sat. NaHCO3, and brine
- dry with materialdried (Na2SO4) and brine
- customThe crude residue was triturated with Et2O
出典と根拠
- ORDレコード
- ord-f36da15899fd4af9811f6c580396af9c
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07094783B2
関連ノート
読み込み中…